Source:http://linkedlifedata.com/resource/pubmed/id/11396303
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2001-6-8
|
pubmed:abstractText |
The mechanisms of the inhibitory effects of verapamil and nitroglycerin on vasospasm were investigated by measuring cytosolic Ca2+ level ([Ca2+]i) and muscle tension in 28 normal specimens and 28 spastic vascular specimens of smooth muscle. Experimental vasospasm was produced by the two-hemorrhage method in the canine basilar artery. [Ca2+]i and tension were recorded simultaneously with a fluorimeter using fura-2. High K+ concentration (72.4 mM) and U-46619 (thromboxane A2 analogue, 10(-8) M) were used as stimulants, and the inhibitory effects of verapamil or nitroglycerin on muscle contraction and increased [Ca2+]i were examined. Verapamil inhibited [Ca2+]i and contraction in high K+ concentration-stimulated arteries. Verapamil inhibited [Ca2+]i more strongly than contraction in U-46619-stimulated arteries. There were no significant differences in the effects of verapamil in the control and vasospasm groups. Nitroglycerin inhibited contraction with little effect on [Ca2+]i in high K+ concentration-stimulated arteries in both the control and vasospasm groups. Nitroglycerin inhibited contraction with little effect on [Ca2+]i in U-46619-stimulated arteries and the inhibitory effect was weaker in the vasospasm group than in the control group. The inhibitory effects of verapamil on muscle tension and [Ca2+]i in vasospastic vessels were as strong as those in normal vessels. In contrast, the inhibitory effects of nitroglycerin were reduced in vasospastic vessels. Increased Ca2+ sensitivity in vasospastic vessels may have reduced the inhibitory effects of nitroglycerin.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channels,
http://linkedlifedata.com/resource/pubmed/chemical/Nitroglycerin,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium,
http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Verapamil
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0470-8105
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
238-44; discussion 244-5
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11396303-Animals,
pubmed-meshheading:11396303-Calcium Channel Blockers,
pubmed-meshheading:11396303-Calcium Channels,
pubmed-meshheading:11396303-Chronic Disease,
pubmed-meshheading:11396303-Cytosol,
pubmed-meshheading:11396303-Disease Models, Animal,
pubmed-meshheading:11396303-Dogs,
pubmed-meshheading:11396303-Drug Therapy, Combination,
pubmed-meshheading:11396303-Female,
pubmed-meshheading:11396303-Male,
pubmed-meshheading:11396303-Muscle, Smooth, Vascular,
pubmed-meshheading:11396303-Muscle Contraction,
pubmed-meshheading:11396303-Nitroglycerin,
pubmed-meshheading:11396303-Potassium,
pubmed-meshheading:11396303-Vasodilator Agents,
pubmed-meshheading:11396303-Vasospasm, Intracranial,
pubmed-meshheading:11396303-Verapamil
|
pubmed:year |
2001
|
pubmed:articleTitle |
Inhibitory effects of verapamil and nitroglycerin on contraction and cytosolic Ca2+ levels in cerebrovascular smooth muscle during chronic cerebral vasospasm.
|
pubmed:affiliation |
Department of Surgical Neurology, Jichi Medical School, Tochigi.
|
pubmed:publicationType |
Journal Article
|